Advanced imaging in surveillance of Barrett's esophagus: Is the juice worth the squeeze?

Advanced imaging in surveillance of Barrett's esophagus: Is the juice worth the squeeze? World J Gastroenterol. 2019 Jul 07;25(25):3108-3115 Authors: Cerrone SA, Trindade AJ Abstract Esophageal cancer is on the rise. The known precursor lesion is Barrett's esophagus (BE). Patients with dysplasia are at higher risk of developing esophageal cancer. Currently the gold standard for surveillance endoscopy involves taking targeted biopsies of abnormal areas as well as random biopsies every 1-2 cm of the length of the Barrett's. Unfortunately studies have shown that this surveillance can miss dysplasia and cancer. Advanced imaging technologies have been developed that may help detect dysplasia in BE. This opinion review discusses advanced imaging in BE surveillance endoscopy and its utility in clinical practice. PMID: 31333304 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31333304?dopt=Abstract

Source: World Journal of Gastroenterology : WJG - July 6, 2019 Category: Gastroenterology Authors: Cerrone SA, Trindade AJ Tags: World J Gastroenterol Source Type: research